Examining how the COVID-19 pandemic has affected overdose rates

Understanding the short- and long-term effects of the COVID-19 pandemic on the overdose crisis

['FUNDING_R01'] · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · NIH-10932904

This study looks at how the COVID-19 pandemic affected overdose rates and aims to find ways to help prevent future overdoses, especially in communities that are more at risk.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorNEW YORK UNIVERSITY SCHOOL OF MEDICINE (nih funded)
Locations1 site (NEW YORK, UNITED STATES)
Trial IDNIH-10932904 on ClinicalTrials.gov

What this research studies

This research investigates the impact of the COVID-19 pandemic on overdose rates, focusing on both short- and long-term effects. It aims to identify which policy measures can prevent future increases in overdose during disasters and to understand why certain communities are more vulnerable. By utilizing Big Events Theory, the research will analyze how pandemic-related policies influenced overdose risks and access to treatment. The goal is to develop targeted prevention strategies for at-risk populations.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals who have experienced substance use issues during the COVID-19 pandemic, particularly those from vulnerable communities.

Not a fit: Patients who have not been affected by substance use or overdose during the pandemic may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved policies that reduce overdose rates during future public health crises.

How similar studies have performed: Other research has shown that understanding the social determinants of health can effectively inform public health responses, suggesting that this approach may yield valuable insights.

Where this research is happening

NEW YORK, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.